NO20042057L - Fosfonsyreforbindelser som inhibitorer av serinproteaser - Google Patents
Fosfonsyreforbindelser som inhibitorer av serinproteaserInfo
- Publication number
- NO20042057L NO20042057L NO20042057A NO20042057A NO20042057L NO 20042057 L NO20042057 L NO 20042057L NO 20042057 A NO20042057 A NO 20042057A NO 20042057 A NO20042057 A NO 20042057A NO 20042057 L NO20042057 L NO 20042057L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- phosphonic acid
- acid compounds
- serine proteases
- proteases
- Prior art date
Links
- 102000012479 Serine Proteases Human genes 0.000 title 1
- 108010022999 Serine Proteases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003009 phosphonic acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33034301P | 2001-10-19 | 2001-10-19 | |
| PCT/US2002/033206 WO2003035654A1 (en) | 2001-10-19 | 2002-10-17 | Phosphonic acid compounds as inhibitors of serine proteases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042057L true NO20042057L (no) | 2004-05-18 |
Family
ID=23289339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042057A NO20042057L (no) | 2001-10-19 | 2004-05-18 | Fosfonsyreforbindelser som inhibitorer av serinproteaser |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20030195172A1 (de) |
| EP (1) | EP1438316B1 (de) |
| JP (1) | JP4423033B2 (de) |
| KR (2) | KR20100074322A (de) |
| CN (1) | CN100506831C (de) |
| AR (1) | AR037245A1 (de) |
| AT (1) | ATE330961T1 (de) |
| AU (1) | AU2002356818C1 (de) |
| BR (1) | BR0213961A (de) |
| CA (1) | CA2464111C (de) |
| CY (1) | CY1105166T1 (de) |
| DE (1) | DE60212675T2 (de) |
| DK (1) | DK1438316T3 (de) |
| ES (1) | ES2266634T3 (de) |
| HK (1) | HK1065802A1 (de) |
| HU (1) | HUP0600339A2 (de) |
| IL (2) | IL161476A0 (de) |
| ME (1) | MEP48708A (de) |
| MX (1) | MXPA04003707A (de) |
| MY (1) | MY133586A (de) |
| NO (1) | NO20042057L (de) |
| NZ (1) | NZ532372A (de) |
| PL (1) | PL209032B1 (de) |
| PT (1) | PT1438316E (de) |
| RS (1) | RS50944B (de) |
| RU (1) | RU2311421C2 (de) |
| WO (1) | WO2003035654A1 (de) |
| ZA (1) | ZA200403824B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459461B2 (en) | 2001-10-19 | 2008-12-02 | Ortho-Mcneil Pharmaceutical, Inc. | Phosphonic acid compounds as inhibitors of serine proteases |
| US7601847B2 (en) | 2004-10-26 | 2009-10-13 | Wyeth | Preparation and purification of 4-(indazol-3-yl)phenols |
| EP2463268B1 (de) | 2004-12-02 | 2013-08-28 | Daiichi Sankyo Company, Limited | 4-(Aminomethyl)benzoesäuren als Zwischenverbindungen für die Herstellung von Chymase-hemmende 1,4-Diazepan-2,5-dion-Verbindungen |
| CA2594106A1 (en) * | 2005-01-06 | 2006-07-13 | Schering Corporation | Preparation of ketone amides |
| KR20080085093A (ko) * | 2006-01-12 | 2008-09-22 | 얀센 파마슈티카 엔.브이. | 키마아제에 의한 ｓｌｐｉ의 프로세싱 |
| US8049006B2 (en) | 2006-05-31 | 2011-11-01 | Daiichi Sankyo Company, Limited | 7-membered ring compound and method of production and pharmaceutical application thereof |
| BRPI0817782A2 (pt) * | 2007-10-16 | 2015-03-24 | Janssen Pharmaceutica Nv | Processo para sintetização de compostos de ácido fosfônico e fosfínico |
| WO2014016870A1 (ja) | 2012-07-24 | 2014-01-30 | 富士通株式会社 | 無線端末、無線基地局、無線通信システムおよび無線通信方法 |
| CN107353305A (zh) * | 2017-07-12 | 2017-11-17 | 浙江普洛得邦制药有限公司 | 一种噁唑烷酮类抗菌药物的三羟甲基氨基甲烷盐及其晶型a、制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2226414A1 (en) * | 1995-07-17 | 1997-02-06 | Cephalon, Inc. | Phosphorous-containing cysteine and serine protease inhibitors |
-
2002
- 2002-10-17 RS YUP-333/04A patent/RS50944B/sr unknown
- 2002-10-17 ES ES02802153T patent/ES2266634T3/es not_active Expired - Lifetime
- 2002-10-17 CA CA2464111A patent/CA2464111C/en not_active Expired - Fee Related
- 2002-10-17 US US10/273,208 patent/US20030195172A1/en not_active Abandoned
- 2002-10-17 PT PT02802153T patent/PT1438316E/pt unknown
- 2002-10-17 PL PL373860A patent/PL209032B1/pl not_active IP Right Cessation
- 2002-10-17 JP JP2003538169A patent/JP4423033B2/ja not_active Expired - Fee Related
- 2002-10-17 DK DK02802153T patent/DK1438316T3/da active
- 2002-10-17 NZ NZ532372A patent/NZ532372A/en not_active IP Right Cessation
- 2002-10-17 IL IL16147602A patent/IL161476A0/xx unknown
- 2002-10-17 DE DE60212675T patent/DE60212675T2/de not_active Expired - Lifetime
- 2002-10-17 EP EP02802153A patent/EP1438316B1/de not_active Expired - Lifetime
- 2002-10-17 WO PCT/US2002/033206 patent/WO2003035654A1/en active Application Filing
- 2002-10-17 MX MXPA04003707A patent/MXPA04003707A/es active IP Right Grant
- 2002-10-17 KR KR1020107011999A patent/KR20100074322A/ko not_active Application Discontinuation
- 2002-10-17 KR KR1020047005810A patent/KR101011175B1/ko not_active IP Right Cessation
- 2002-10-17 AU AU2002356818A patent/AU2002356818C1/en not_active Ceased
- 2002-10-17 ME MEP-487/08A patent/MEP48708A/xx unknown
- 2002-10-17 BR BR0213961-8A patent/BR0213961A/pt not_active Application Discontinuation
- 2002-10-17 RU RU2004111784/04A patent/RU2311421C2/ru not_active IP Right Cessation
- 2002-10-17 AT AT02802153T patent/ATE330961T1/de active
- 2002-10-17 CN CNB028250982A patent/CN100506831C/zh not_active Expired - Fee Related
- 2002-10-17 HU HU0600339A patent/HUP0600339A2/hu unknown
- 2002-10-21 AR ARP020103969A patent/AR037245A1/es unknown
- 2002-10-21 MY MYPI20023912A patent/MY133586A/en unknown
-
2004
- 2004-04-18 IL IL161476A patent/IL161476A/en not_active IP Right Cessation
- 2004-05-18 ZA ZA200403824A patent/ZA200403824B/en unknown
- 2004-05-18 NO NO20042057A patent/NO20042057L/no not_active Application Discontinuation
- 2004-11-08 HK HK04108770A patent/HK1065802A1/xx not_active IP Right Cessation
-
2006
- 2006-08-23 CY CY20061101180T patent/CY1105166T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0701538L (sv) | Azaspiroalkanderivat som hämmare av metalloproteaser | |
| NO20043158L (no) | Substituerte kinazolinderivater som inhibitorer av aurorakinaser | |
| NO20033593L (no) | Kinazoliner som MMP-13 inhibitorer | |
| NO20043102L (no) | Fjerning av sure gasser | |
| NO20033399L (no) | Eterderivater anvendelige som inhibitorer av PDE4-isoenzymer | |
| NO20014837L (no) | Pyrazolsammensetninger nyttige som inhibitorer av ERK | |
| NO20004696D0 (no) | Kinoloner som serinproteaseinhibitorer | |
| NO20050563L (no) | N-aryl-piperidinsubstituerte bifenylkarboksamider som inhibitorer av apolipoprotein B-sekresjon | |
| IL155202A0 (en) | Biaryl compounds as serine protease inhibitors | |
| NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
| WO2006047528A3 (en) | Pyrazolobenzamides and derivatives as factor xa inhibitors | |
| DK1132570T3 (da) | Sammensætninger til syrebehandling af borebrönde | |
| GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
| NO20034045D0 (no) | Metallproteinase-inhibitorer | |
| DK1458447T3 (da) | Kombination af cytokrom-p450-beroende proteasinhibitorer | |
| NO20042679L (no) | Inhibitorer av cytosolisk fosfolipase A2 | |
| CY1105166T1 (el) | Ενωσεις φωσφονικου οξεος σαν αναστολεις πρωτεασων σepινης | |
| NO20055396L (no) | Nye fosfonsyreforbindelser som serinproteaseinhibitorer | |
| AU2001296515A1 (en) | Cyclic sulfonyl compounds as inhibitors of metalloproteases | |
| DK1353930T3 (da) | Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre | |
| NO20023921D0 (no) | Derivater av thiazepinylhydroksamisk syre som inhibitorer av matriks metalloproteinase | |
| EP1594845A4 (de) | Als serinproteaseinhibitoren geeignete benzolacetamidverbindungen | |
| WO2004108892A3 (en) | 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | |
| FI20031191A (fi) | Monoamiinin takaisinoton estäjä | |
| NO20033166D0 (no) | Prodrugs for eksitasjon av aminosyrer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |